# EIN Presswire news releases (page 10)

Press releases companies distribute through EIN Presswire, syndicated on Connectively Wire to the journalists who cover the beat.

- **Releases in the last 90 days:** 113
- **Website:** https://www.einpresswire.com
- **Web page:** https://www.connectively.us/news-releases/ein-presswire?page=10
- **RSS:** https://www.connectively.us/news-releases/ein-presswire/rss.xml

### [SFO Harvey Milk Terminal 1 Named 2026 DBIA Project of the Year](https://www.connectively.us/news-releases/sfo-harvey-milk-terminal-1-named-2026-dbia-project-of-the-year)

November 9, 2026 · Design-Build Institute of America · Building & Construction Industry · WASHINGTON, DC, UNITED STATES

San Francisco International Airport's Harvey Milk Terminal 1 has earned the Design-Build Institute of America's (DBIA) highest project honor, 2026 National Design-Build Project of the Year, recognizing a major airport transformation delivered through progressive design-build…

### [NASCOM and Karman Line, Inc. Sign MOU to Form Space Coast Oman Joint Venture](https://www.connectively.us/news-releases/nascom-and-karman-line-inc-sign-mou-to-form-space-coast-oman-joint)

November 9, 2026 · Karman Line · Business & Economy · MUSCAT, OMAN

Oman’s National Aerospace Services Company (NASCOM) and Karman Line, Inc., a Cape Canaveral, Florida-based developer of spaceport-adjacent infrastructure, have signed a memorandum of understanding to establish Space Coast Oman.

### [Warning Signs of Ceuta Mass Border Crossing Were Visible Online Weeks Before It Happened, Vetric Research Finds](https://www.connectively.us/news-releases/warning-signs-of-ceuta-mass-border-crossing-were-visible-online-weeks)

November 8, 2026 · Vetric · Technology · TEL AVIV, ISRAEL

Vetric, the video intelligence company, today published Below the Caption: The Digital Footprint of the Ceuta Border Crossing, independent research showing that the warning signs of the summer 2026 mass border crossing into Ceuta were publicly visible online days and weeks…

### [Novaspira Biotherapeutics Reports Phase 1 Data for a Novel GPC3x4-1BB Bispecific in Late-Breaking Oral at SITC 2026](https://www.connectively.us/news-releases/novaspira-biotherapeutics-reports-phase-1-data-for-a-novel-gpc3x4-1bb-2)

November 7, 2026 · Novaspira Biotherapeutics · Healthcare & Pharmaceuticals Industry · CHATHAM, NJ, UNITED STATES

Chatham, NJ, November 7, 2026: Novaspira Biotherapeutics today announced the presentation of first-in-human clinical data for BOS-342 (NS-342), a novel GPC3 × 4-1BB bispecific immunotherapy, in patients with advanced hepatocellular carcinoma (HCC).

Page 10 of 10. [Previous page](https://www.connectively.us/news-releases/ein-presswire.md?page=9)
